The influence of germline genetics on tumor biology has been investigated in The Cancer Genome Atlas (TCGA), in which a decreased frequency of VHL and PBRM1 mutations was identified among patients with elevated African (AFR) ancestry, relative to European (EUR) ancestry (10). This evidence concerns the gene VHL and neoplasm.